Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for ClearPoint Neuro, Inc. (CLPT : NSDQ)
 
 • Company Description   
ClearPoint Neuro Inc. provides neurosurgery platform which includes hardware, software, clinical case and market development services for gene therapy cases principally in the United States and Europe. ClearPoint Neuro Inc., formerly known as MRI Interventions Inc., is based in Irvine, California.

Number of Employees: 80

 
 • Price / Volume Information   
Yesterday's Closing Price: $9.35 Daily Weekly Monthly
20 Day Moving Average: 235,624 shares
Shares Outstanding: 23.71 (millions)
Market Capitalization: $221.67 (millions)
Beta: 1.26
52 Week High: $22.80
52 Week Low: $7.00
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -11.21% -3.10%
12 Week 18.50% 24.76%
Year To Date -16.67% -2.86%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
120 S. SIERRA AVE. SUITE 100
-
SOLANA BEACH,CA 92075
USA
ph: 888-287-9109
fax: 949-900-6834
hhurwitz@clearpointneuro.com http://www.clearpointneuro.com
 
 • General Corporate Information   
Officers
Joseph M. Burnett - Chief Executive Officer and President
R. John Fletcher - Chairman
Danilo D'Alessandro - Chief Financial Officer
Lynnette C. Fallon - Director
Pascal E.R. Girin - Director

Peer Information
ClearPoint Neuro, Inc. (ABMD)
ClearPoint Neuro, Inc. (DMDS)
ClearPoint Neuro, Inc. (CPWY.)
ClearPoint Neuro, Inc. (EQUR)
ClearPoint Neuro, Inc. (ECIA)
ClearPoint Neuro, Inc. (FMS)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: MED INSTRUMENTS
Sector: Medical
CUSIP: 18507C103
SIC: 3841
Fiscal Year
Fiscal Year End: December
Last Reported Quarter: 03/01/22
Next Expected EPS Date: 08/09/22
Share - Related Items
Shares Outstanding: 23.71
Most Recent Split Date: 7.00 (0.03:1)
Beta: 1.26
Market Capitalization: $221.67 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $-0.18 Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $-0.72 Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 08/09/22  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: 4.85
Price/Cash Flow: -
Price / Sales: 12.81
EPS Growth
vs. Year Ago Period: -30.77%
vs. Previous Quarter: 10.53%
Sales Growth
vs. Year Ago Period: 24.84%
vs. Previous Quarter: 17.49%
ROE
03/31/22 - -33.94
12/31/21 - -31.18
09/30/21 - -34.22
ROA
03/31/22 - -23.59
12/31/21 - -20.52
09/30/21 - -19.35
Current Ratio
03/31/22 - 14.60
12/31/21 - 13.02
09/30/21 - 14.17
Quick Ratio
03/31/22 - 13.16
12/31/21 - 11.98
09/30/21 - 13.31
Operating Margin
03/31/22 - -91.51
12/31/21 - -88.41
09/30/21 - -75.28
Net Margin
03/31/22 - -91.51
12/31/21 - -88.41
09/30/21 - -75.28
Pre-Tax Margin
03/31/22 - -91.51
12/31/21 - -88.41
09/30/21 - -75.28
Book Value
03/31/22 - 1.93
12/31/21 - 2.06
09/30/21 - 1.97
Inventory Turnover
03/31/22 - 1.18
12/31/21 - 1.27
09/30/21 - 1.45
Debt-to-Equity
03/31/22 - 0.22
12/31/21 - 0.20
09/30/21 - 0.40
Debt-to-Capital
03/31/22 - 17.72
12/31/21 - 16.78
09/30/21 - 28.53
 

Powered by Zacks Investment Research ©